BILIBILI INC-SPONSORED ADR
BILINASDAQ🏆 #1147 by market capEarnings Nov 9US Equity
$14.84▼ $0.29 (−1.98%)
🌙 After hours$14.89▲ 0.34%Regular close · extended-hours price shownTrack BILI
Get earnings, price moves & breaking news on Telegram
24h▼ 2.0%
7d▼ 1.2%
14d▼ 0.4%
30d▼ 8.1%
ytd▼ 39.7%
1y▼ 47.2%
🏦Market Cap
$6.22B
Small Cap
📈Revenue Growth (YoY)
+13.1%
Healthy
📊Gross Margin
37.3%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
1.4x
Cheap
Otter Score
68
Fair
BILIBILI INC-SPONSORED ADR
BILIAnalyst Ratings
Price
$14.84
Total
24
Raised
8
Lowered
2
Avg PT
$27.25
H / L
$30 / $23
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2026-04-13 | $27.00 | +81.90% |
Citigroup | Upgraded | Neutral → Buy | 2026-03-27 | $18.00 | +21.30% |
JP Morgan | Upgraded | Neutral → Overweight | 2026-03-17 | — | — |
B of A Securities | Reiterated | Buy | 2025-11-28 | — | — |
Barclays | Reiterated | Overweight | 2025-11-14 | $34.00 | +129.10% |
Benchmark | Reiterated | Buy | 2025-11-14 | — | — |
Bernstein | Reiterated | Outperform | 2025-10-23 | $32.00 | +115.60% |
HSBC | Upgraded | Hold → Buy | 2025-05-21 | — | — |
Mizuho | Reiterated | Outperform | 2024-11-12 | — | — |
Nomura | Upgraded | Neutral → Buy | 2024-08-22 | $18.00 | +21.30% |
UBS | Upgraded | Neutral → Buy | 2024-05-31 | $18.00 | +21.30% |
CLSA | Reiterated | Outperform → Buy | 2024-05-10 | $16.80 | +13.20% |
Goldman Sachs | Reiterated | Neutral | 2023-11-30 | $22.60 | +52.30% |
Baird | Reiterated | Neutral | 2023-08-18 | — | — |
Deutsche Bank | Reiterated | Buy | 2021-08-13 | $110.00 | +641.20% |
86 Research | Upgraded | Hold → Buy | 2021-05-14 | — | — |
Credit Suisse | Upgraded | Neutral → Outperform | 2021-04-08 | $139.00 | +836.70% |
Nomura Instinet | Downgraded | Buy → Neutral | 2020-08-27 | — | — |
BOCOM International | Downgraded | Buy → Neutral | 2020-07-17 | — | — |
Citi | Reiterated | Buy | 2019-08-27 | — | — |
Jefferies | Reiterated | Buy | 2019-08-05 | $28.00 | +88.70% |
China Renaissance | Reiterated | Buy | 2019-02-27 | — | — |
Daiwa Capital | Reiterated | Outperform | 2019-01-14 | — | — |
Bank of America | Reiterated | Buy | 2018-09-11 | — | — |
Institution
Morgan Stanley
Upgraded · Equal Weight → Overweight · 2026-04-13
$27.00
+81.90%
Citigroup
Upgraded · Neutral → Buy · 2026-03-27
$18.00
+21.30%
JP Morgan
Upgraded · Neutral → Overweight · 2026-03-17
—
—
B of A Securities
Reiterated · Buy · 2025-11-28
—
—
Barclays
Reiterated · Overweight · 2025-11-14
$34.00
+129.10%
Benchmark
Reiterated · Buy · 2025-11-14
—
—
Bernstein
Reiterated · Outperform · 2025-10-23
$32.00
+115.60%
HSBC
Upgraded · Hold → Buy · 2025-05-21
—
—
Mizuho
Reiterated · Outperform · 2024-11-12
—
—
Nomura
Upgraded · Neutral → Buy · 2024-08-22
$18.00
+21.30%
UBS
Upgraded · Neutral → Buy · 2024-05-31
$18.00
+21.30%
CLSA
Reiterated · Outperform → Buy · 2024-05-10
$16.80
+13.20%
Goldman Sachs
Reiterated · Neutral · 2023-11-30
$22.60
+52.30%
Baird
Reiterated · Neutral · 2023-08-18
—
—
Deutsche Bank
Reiterated · Buy · 2021-08-13
$110.00
+641.20%
86 Research
Upgraded · Hold → Buy · 2021-05-14
—
—
Credit Suisse
Upgraded · Neutral → Outperform · 2021-04-08
$139.00
+836.70%
Nomura Instinet
Downgraded · Buy → Neutral · 2020-08-27
—
—
BOCOM International
Downgraded · Buy → Neutral · 2020-07-17
—
—
Citi
Reiterated · Buy · 2019-08-27
—
—
Jefferies
Reiterated · Buy · 2019-08-05
$28.00
+88.70%
China Renaissance
Reiterated · Buy · 2019-02-27
—
—
Daiwa Capital
Reiterated · Outperform · 2019-01-14
—
—
Bank of America
Reiterated · Buy · 2018-09-11
—
—
One row per institution · price target from the firm's latest published target